VVN-001

N/A

Report date: 2026/03/09 20:02:04
NME

Base Information

Drug NameVVN-001
Drug Alias NameVVN001VVN-001
ClassificationSmall molecules
Mechanisms of ActionLeukocyte adhesion glycoprotein LFA-1 alpha antagonists
TargetsLeukocyte adhesion glycoprotein LFA-1 alpha
Therapy Area/IndicationsXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesVivaVision Biotech Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesVivaVision Biotech Inc
Inactive CompaniesN/A
Active IndicationsXerophthalmia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A